Dr. Gleave to give MSFHR-VCHRI lecture on the PC-TRiADD Model

Date Posted: 
2014-01-09

The Michael Smith Foundation for Health Research (MSFHR) and the Vancouver Coastal Research Institute are pleased to present a lecture by one of British Columbia’s most innovative scientists — a man who has bridged the gap between clinical research and new commercial treatments for disease.

Dr. Martin Gleave is the most recent recipient of the MSFHR Aubrey J. Tingle Prize, given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research — as well as its uptake — to improve health and the health system in BC and globally.

Please join Dr. Diane Finegood, MSFHR president and CEO, as she presents Dr. Gleave with his award. Dr. Gleave will also deliver a lecture and take questions from the audience.

Title:  Bridging the Mind to Market Gap in Translational Cancer Research: The Vancouver PC-TRiADD Model

Presenter:  Dr. Martin Gleave MD, FRCSC, FACS

Date:  Tuesday, January 14, 2014

Time:  4 – 5 p.m. (presentation and lecture); 5 – 6 p.m. (reception)

Location: Paetzold Auditorium & Atrium, 1st Floor, Jim Pattison Pavilion, Vancouver General Hospital, 855 West 12th Avenue

Dr. Martin Gleave is executive director of the Vancouver Prostate Centre, chief executive officer of PC-TRIADD, and a distinguished professor in the department of urologic sciences at UBC. His major research focus involves the study of cellular and molecular mechanisms mediating progression of prostate cancer to its lethal stage of androgen independence, and use of this information to develop integrated multimodality therapies that specifically target these mechanisms. He is the scientific founder of OncoGenex Pharmaceuticals Inc.

The Michael Smith Foundation for Health Research harnesses the power of health research to improve the health of British Columbians and their health system. It does this by building BC’s capacity for world-class research by funding the best scientists; coordinating the sharing of health research resources across the province; and bringing people together for health research planning and action. Learn more at www.msfhr.org.

Vancouver Coastal Health Research Institute (VCHRI) is the research body of Vancouver Coastal Health. VCHRI includes three of BC’s largest academic and teaching health sciences centres — Vancouver General Hospital, UBC Hospital, and GF Strong Rehabilitation Centre — as well as many other hospitals and public health agencies across Vancouver Coastal Health. VCHRI is academically affiliated with the UBC Faculty of Medicine and is one of Canada’s top funded research centres receiving between $80 and $100 million in research funding annually.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.